GeoVax Labs, Inc. (NASDAQ: GOVX), a trailblazer in the biotechnology arena, is steadily carving its niche in the development of vaccines and immunotherapies targeting infectious diseases and cancers. The company recently celebrated a significant milestone: the U.S. Patent and Trademark Office (USPTO)…
